Results 71 to 80 of about 1,630,140 (194)

Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopenias

Transfusion Medicine, EarlyView.
Abstract Background Thrombocytopenia arises from heterogeneous inherited and acquired disorders, and identifying the underlying platelet clearance mechanisms remains challenging. Platelet desialylation, characterised by loss of sialic acid and consequent exposure of terminal β‐galactose residues recognised by the Ashwell–Morell receptor, represents an ...
Karen Nogueira Chinoca Ziza, Thamy Caroline Silva, Mateus Domentino, Marina Cavalcanti Albuquerque Veiga Conrado, João Vitor Bernardo Oliveira, Felipe Augusto Rós, Caroline Gabe, Elyse Moritz, Akemi Chiba, Paula Villaça, Vanderson Rocha, Alfredo Mendrone‐Junior, José Bordin, Dante Langhi, Carla Luana Dinardo   +14 more
wiley   +1 more source

Comparative analysis of characteristics and functions of exosomes from human induced pluripotent stem cell-derived platelets and apheresis platelets

Zhongguo shuxue zazhi
[Objective] To compare the biological characteristics of human induced pluripotent stem cell-derived platelet exosomes (hiPSC-Plt-Exos) with those of conventional apheresis platelet exosomes (Plt-Exos), specifically focusing on their differential ...
HUANG Weihua, ZANG Yan, QIN Aihua, FENG Ziyang, TANG Heshan, GUO Fei, WU Chuyan, SHEN Qiu, QIAN Baohua, GU Haihui, CHA Zhanshan   +10 more
doaj   +1 more source

Guidelines on the Use of Therapeutic Apheresis in Clinical PracticeEvidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

, 2013
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis.
Williams, Mark E., Wu, Yanyun, Winters, Jeffrey L., Delaney, Meghan, Shaz, Beth H., Schwartz, Joseph, Padmanabhan, Anand, Szczepiorkowski, Zbigniew M., Linenberger, Michael L., Balogun, Rasheed A.   +9 more
core   +1 more source

HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study

Transfusion Medicine, EarlyView.
Abstract Introduction Human T‐cell lymphotropic virus types 1 and 2 (HTLV‐1/2) are transfusion‐transmissible retroviruses associated with severe diseases, and blood donor screening is mandatory in Brazil. Increasing HTLV‐related discard rates at our institution prompted this study to determine the prevalence and incidence of HTLV‐1/2 and to investigate
Suzete C. Ferreira, Anna S. Nishyia, Jerenice E. Ferreira, Claudia Di Lorenzo Oliveira, Cesar de Almeida‐Neto, Tila Fanciani, Katia C. Dantas, Juliana Derriga, Silvia Petrossi Gallo Polato, Nanci Salles, Vanderson Rocha, Alfredo Mendrone‐Junior   +11 more
wiley   +1 more source

World apheresis registry report

, 2007
The establishment of national apheresis registries has been helpful to learn about therapeutic profiles and adverse event incidences. During 2003, the World Apheresis Registry was established and centers from all countries were invited to participate to ...
Stegmayr, Bernd,, Ptak, Jan,, Wikström, Björn,, Ptak, Jan, Stegmayr, Bernd   +4 more
core   +1 more source

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

Transfusion, EarlyView.
Abstract Background During the COVID‐19 pandemic, convalescent plasma (CP) was investigated as a potential treatment. We assess the financial resources required to implement a COVID‐19 CP (CCP) programme and provide recommendations on how best to prepare for collection and use of CP in future pandemics.
Elizabeth A. Stokes, Abigail A. Lamikanra, David J. Roberts, Lise J. Estcourt, Pierre Tiberghien, Jose Leal   +5 more
wiley   +1 more source

Therapeutic apheresis in hematopoietic cell transplantation

Turkish Journal of Hematology, 2008
With the introduction of hematopoietic stem cell transplant (HSCT), transplant-associated problems like graft-versus-host disease (GVHD) and transplant-associated microangiopathy (TAM) have occurred. In addition, approximately 40% of allogeneic HSCTs are
Paul Höcker, Hildegard T Greinix, Andrea Wagner, Gerda Leitner, Nina Worel, Peter Kalhs   +5 more
doaj  

An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee

The American Society for Apheresis (ASFA) Attending Physician Subcommittee of the Physicians' Committee performed an annual review of articles published in 2024 related to apheresis medicine. The 10 seminal apheresis articles selected by the subcommittee
Alsammak, Mohamed, Wu, Ding Wen, Tanhehco, Yvette C, Saint Martin, Marisa C, Stephens, Laura D, Lu, Wen, Mattiazzi, Adela D, Singh, Nirupama, Banez-Sese, Grace, Noland, Daniel K, Levenbrown, Yosef, Gupta, Gaurav K, Siwach, Garima, Li, Yanhua, Costa, Victoria, Chhibber, Vishesh, Wehrli, Gay   +16 more
core   +1 more source

Clinical performance and limitations of a vital sign‐based electronic automatic notification system for suspected transfusion reactions: A 6‐year experience

Transfusion, EarlyView.
Abstract Background Automated surveillance systems such as the electronic automatic notification system (EANS) have been introduced to improve recognition of adverse transfusion reactions (ATRs), but their long‐term sustainability and operational limitations remain incompletely defined. Study Design and Methods We conducted a 6‐year retrospective study
Young Ae Lim, Chorong Park, Jin Kim
wiley   +1 more source

Therapeutic apheresis. Applications and future directions.

, 1983
The past 10-15 years have been witness to major technological achievements in the field of therapeutic apheresis. Concurrently, a large number of diseases, primarily with an immunological basis, have been treated with apheresis.
Kennedy, M S, Domen, R E
core   +1 more source